In the years leading up to the bankruptcy, the Sacklers took about $11 billion out of Purdue, more than 70% of the company's total assets. 60 Minutes requested interviews with members of Richard ...

Oxycontin maker Purdue Pharma received court approval on Friday to begin voting on its $7.4 billion bankruptcy settlement, while deferring questions about how state and local governments should ...

Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.

All 50 states as well as the District of Columbia and U.S. territories have approved a $7.4 billion settlement with Purdue Pharma, maker of Oxycontin, over the company's improper marketing of opioids.

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement resolving lawsuits over its alleged role in the opioid crisis, months after the Supreme Court blocked a prior deal.

Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case.

OxyContin maker Purdue Pharma ’s latest plan to settle thousands of lawsuits over the toll of opioids could soon move forward after every U.S. state involved agreed to it. A judge on Wednesday ...

Purdue’s attorney Marshall Huebner told U.S. Bankruptcy Judge Sean Lane at a hearing in White Plains, New York, that the Sacklers might pay up to $500 million more than previously announced ...

Roiling headlines in the last couple of years were the bankruptcy filings of the corporations Purdue Pharma and the national organization of Boy Scouts of America (now called Scouting America).

Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic victims and fund addiction treatment programs. The Stamford, Connecticut ...